CNR1 and Hyperglycemia: Encouraged by the findings that genetic deletion of CB1R in RPTCs and its pharmacological blockade by SLV-319 protected mice from the deleterious effects of hyperglycemia on the skeleton, we next tried to suggest a molecular effector linking kidney CB1R with bone remodeling and mass.